£66.20

It has never been this cheap. We have no record of a lower price.

£66 today · cheaper than every other day in the last 2 months

ÉDITIONS UNIVERSITAIRES EUROPÉENNES Diagnostic et traitement des leucémies aiguës lymphoblastiques

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 5 days · 5 data points (no recent data)

Historical
Generating forecast…
£66.20 £62.89 £64.21 £65.54 £66.86 £68.19 £69.51 11 September 2026 12 September 2026 13 September 2026 14 September 2026 15 September 2026
View at Amazon ↗

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 5 days • 1 price levels

Days at Price
5 days 0 1 3 4 5 £66 Days at Price

Price Analysis

Most common price: £66 (5 days, 100.0%)

Price range: £66 - £66

Price levels: 1 different prices over 5 days

Description

La LAL a reconnu des progrès thérapeutiques significatifs chez l'enfant. Cependant, chez l'adulte, les résultats sont encore non satisfaisants. Nos résultats sont cependant moins encourageants. Évaluer les résultats du protocole GRAALL et GRAAPH dans le traitement des LAL de l'adulte et proposer un algorithme thérapeutique adapté aux facteurs pronostiques validés chez nos patients.Notre étude est rétrospective. Elle a inclus les adultes suivis pour une LAL diagnostiquée au service d'hématologie du CHU Hédi Chaker de Sfax. Nous avons étudié les caractéristiques diagnostiques, les résultats thérapeutiques, évolutifs et les facteurs pronostiques de notre population.Nous avons colligé 49 patients, avec un sex ratio de 0,88. La médiane d'âge était de 42 ans. Une hyperleucocytose >30 G/l était constatée chez 28% des cas. Il s'agit de LAL-B dans 65% des cas, de LAL-T dans 33% des cas et biphénotypique dans 2%. Le caryotype était concluant dans 70%, dont 54% avaient des anomalies cytogénétiques. Le taux global de RC étaitde 93% pour les LAL non-phi+ et de 90% pour les LAL phi+, celui d'échec était respectivement de 5% et 10%.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
22 August 2024
Listed Since
16 September 2024

Barcode

No barcode data available

Similar Products You Might Like

Studio della genetica cito-molecolare di alcuni pazienti iracheni affetti da ALL: Studio delle alterazioni genetiche e del livello di danno al DNA in alcuni pazienti iracheni affetti da ALL
79% match

Studio della genetica cito-molecolare di alcuni pazienti iracheni affetti da ALL: Studio delle alterazioni genetiche e del livello di danno al DNA in alcuni pazienti iracheni affetti da ALL

£56.00 15 Sep 2026
Fusion Oncogenes & Acute Lymphoblastic Leukemia in Adults: A study of prognostically significant fusion oncogenes in ALL patients in Pakistan & their correlation with the disease
79% match

Fusion Oncogenes & Acute Lymphoblastic Leukemia in Adults: A study of prognostically significant fusion oncogenes in ALL patients in Pakistan & their correlation with the disease

LAP Lambert Academic Publishing

£54.00 04 Nov 2026
Childhood Acute Lymphoblastic Leukemia
77% match

Childhood Acute Lymphoblastic Leukemia

Springer

£92.00 24 Oct 2026
Genetic Changes and Their Prognostic Impact In Leukaemia Patients: Characterization of Cytogenetic and Molecular Genetic Changes and Their Prognostic impact in Acute Leukaemia Patients
76% match

Genetic Changes and Their Prognostic Impact In Leukaemia Patients: Characterization of Cytogenetic and Molecular Genetic Changes and Their Prognostic impact in Acute Leukaemia Patients

LAP Lambert Academic Publishing

£61.00 07 Nov 2026
Handbook of Leukemia
76% match

Handbook of Leukemia

Hayle Medical

£78.42 24 Oct 2026
Chronic Lymphocytic Leukemia: New Research
76% match

Chronic Lymphocytic Leukemia: New Research

£109.99 15 Sep 2026
Adult T-cell Leukemia/Lymphoma
75% match

Adult T-cell Leukemia/Lymphoma

Springer

£99.11 27 Oct 2026
Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)
74% match

Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)

Humana

£80.67 23 Oct 2026
Atlas of Hematologic Neoplasms
74% match

Atlas of Hematologic Neoplasms

Springer

£193.00 03 Nov 2026
Acute Lymphocytic Leukemia and Ecto-and Endo-Parasites: Association of acute lymphocytic leukemia in children with some Ecto-and Endo-parasites
74% match

Acute Lymphocytic Leukemia and Ecto-and Endo-Parasites: Association of acute lymphocytic leukemia in children with some Ecto-and Endo-parasites

LAP Lambert Academic Publishing

£48.00 27 Aug 2026
Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies
74% match

Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies

Springer

£84.64 23 Oct 2026
Unclassifiable Leukemias: Proceedings of a Symposium, held on October 11 - 13, 1974 at the Institute of Cell Pathology, Hopital de Bicetre, Paris, France.
74% match

Unclassifiable Leukemias: Proceedings of a Symposium, held on October 11 - 13, 1974 at the Institute of Cell Pathology, Hopital de Bicetre, Paris, France.

Springer

£85.68 27 Oct 2026
Chronic Myeloid Leukemia (Hematologic Malignancies)
74% match

Chronic Myeloid Leukemia (Hematologic Malignancies)

Springer

£109.97 23 Oct 2026
Advances in the Treatment of B-Cell Chronic Lymphocytic Leukemia
73% match

Advances in the Treatment of B-Cell Chronic Lymphocytic Leukemia

£60.00 30 Oct 2026
Leukemia - Incorporating Acute & Chronic ALL, AML, CLL & CML
73% match

Leukemia - Incorporating Acute & Chronic ALL, AML, CLL & CML

CREATESPACE

£45.99 22 Oct 2026
Untersuchung der DNA-Methylierung zellzyklus- und differenzierungsrelevanter Gene als mögliche Prognosefaktoren der akuten lymphatischen Leukämie mittels Pyrosequenzierung
73% match

Untersuchung der DNA-Methylierung zellzyklus- und differenzierungsrelevanter Gene als mögliche Prognosefaktoren der akuten lymphatischen Leukämie mittels Pyrosequenzierung

GRIN Verlag

£52.89 04 Nov 2026
Efficacy and Mechanism of Typhonium flagelliforme in Leukemia
73% match

Efficacy and Mechanism of Typhonium flagelliforme in Leukemia

LAP Lambert Academic Publishing

£68.00 07 Nov 2026
Childhood Leukemia: A Practical Handbook (Pediatric Oncology)
73% match

Childhood Leukemia: A Practical Handbook (Pediatric Oncology)

Springer

£100.25 14 Sep 2026
Invasive Mykosen bei Patienten mit akuter myeloischer Leukämie: Inzidenz, Letalität und Analyse der Diagnosekriterien der European Organization for Research and Treatment of Cancer
73% match

Invasive Mykosen bei Patienten mit akuter myeloischer Leukämie: Inzidenz, Letalität und Analyse der Diagnosekriterien der European Organization for Research and Treatment of Cancer

£45.00 05 Sep 2026
The effect of GR modulators on leukemia cells
73% match

The effect of GR modulators on leukemia cells

LAP Lambert Academic Publishing

£75.00 09 Sep 2026
Myelodysplastic Syndromes: Diagnosis - Prognosis - Therapy (Hematologic Malignancies)
73% match

Myelodysplastic Syndromes: Diagnosis - Prognosis - Therapy (Hematologic Malignancies)

Springer

£73.14 17 Oct 2026
Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)
73% match

Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)

Humana

£95.74 23 Oct 2026
73% match

Chronic Lymphoid Leukemia, An Issue of Hematology/Oncology Clinics of North America, 1e: Volume 26-5 (The Clinics: Internal Medicine)

Elsevier

£67.99 01 Nov 2026
Diagnóstico y tratamiento de la leucemia linfoblástica aguda
73% match

Diagnóstico y tratamiento de la leucemia linfoblástica aguda

£67.00 09 Sep 2026